Orano Med Partners with UK's Orbit Discovery to Develop Therapies for Cancer Cells September 13, 2023 French-US origin biotechnology company Orano Med has partnered with UK-based Orbit Discovery to develop Peptide Receptor Radionuclide therapies for cancer cells and create new radiopharmaceuticals.
Lupin Partners with Businesses to Expand Medicine Access for COPD Patients in the US September 7, 2023